UNC School of Medicine announces new kind of test for COVID-19
Category: #health  By Mateen Dalal  Date: 2020-06-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

UNC School of Medicine announces new kind of test for COVID-19

With the number of people testing positive for COVID-19 increasing to over 7.5 million, the need for extensively applicable surveillance testing for better understanding of infection rates, particularly the number of infections in people with no or mild symptoms, is of paramount importance.

In a bid to simplify COVID-19 testing across the globe, researchers at UNC School of Medicine have reportedly developed a new kind of antibody test that would help labs that don’t have resources of commercial labs and academic centers to test thousands of blood samples.

Sources cite that the researchers created a blood test to identify SARS-CoV-2 antibodies that target RBD (Receptor Binding Domain) of the SARS-CoV-2 spike protein. The RBD-based antibody test measures the levels of that domain which associate to the levels of the important neutralizing antibodies that strengthen immunity.

The RBD of the spike protein in coronavirus is not shared among other known animal and human coronaviruses. Thus, antibodies against this domain are highly specific to SARS-CoV-2. These antibodies are present in the individuals who have been exposed to the coronavirus related to COVID-19.

Certainly, when scientists tested blood collected from individuals exposed to other types of coronaviruses, no one had antibodies to the RBD of SARS-CoV-2.

Commenting on this new study, co-senior author Aravinda de Silva said that the study is very specific for antibodies to the SARS-COV-2, which is not the case for some existing available antibody tests.

Mr. De Silva added that the study’s outcomes strongly support the use of RBD-based antibody evaluates for population-level observation and as a correlate of the neutralizing antibody levels in individuals who have recovered from COVID-19.

For the development of this new testing methods, researchers studied large number of SARC-Cov-2 infected patients.

Source Credit - https://www.news-medical.net/news/20200611/UNC-scientists-develop-new-kind-of-antibody-test-for-COVID-19.aspx

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
By Mateen Dalal

According to reliable sources, British-Swedish multinational pharmaceutical company AstraZeneca plc will present the much awaited results of the Phase III DAPA-CKD trial of Farxiga in CKD (chronic kidney disease) at ESC Congress 2020. Sources with r...

FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
By Mateen Dalal

Abbott Laboratories, a U.S.-based medical devices and healthcare firm, has reportedly received the Emergency Use Authorization (EUA) from the U.S. FDA (Food and Drug Administration) for the detecting COVID-19 virus with its portable antigen test Bina...

Hyundai Wia Corp. signs gun parts export contract with BAE Systems
Hyundai Wia Corp. signs gun parts export contract with BAE Systems
By Mateen Dalal

Hyundai Wia Corp., a South Korea-based defense firm, has reportedly signed gun parts export contract with BAE Systems plc of worth USD 100 million via a pre-value accumulation system. As per the agreement, Hyundai Wia will supply over 106 types of gu...